Divis Laboratories Ltd | DIVI - Nettoeinkommen

Aktienkurs
6,530.00
Täglich Wechseln
97.50 1.52%
Monatlich
9.80%
Jährlich
7.28%
Q2 Prognose
6,221.55




Nettoeinkommen Veränderung Datum
Alaunos Therapeutics USD -1.16M 108K 2025-09
Aurobindo Pharma INR 9.1B 618.4M 2025-12
Avita Medical AUD -11.62M 1.7M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 5.83B 1.06B 2025-12
Ionis Pharmaceuticals USD -93M 136M 2026-03
IQVIA Holdings USD 514M 183M 2025-12
Lupin INR 11.76B 3.02B 2025-12
Moderna USD -200M 625M 2025-09
Organon & Co USD 160M 15M 2025-09
Revvity USD 98.36M 51.71M 2025-12
Tectonic Therapeutic USD -19.23M 186K 2025-12
Tilray USD -44.93M 44.61M 2025-09
Viatris USD -340.1M 211.9M 2025-12
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12